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Abstract
We performed variance components linkage analysis in nuclear families from the Framingham
Heart Study on nine phenotypes derived from systolic blood pressure (SBP). The phenotypes were
the maximum and mean SBP, and SBP at age 40, each analyzed either uncorrected, or corrected
using two subsets of epidemiological/clinical factors. Evidence for linkage to chromosome 8p was
detected with all phenotypes except the uncorrected maximum SBP, suggesting this region harbors
a gene contributing to variation in SBP.
Background
Linkage analysis of quantitative traits holds great promise
for dissecting the genetic contribution of phenotypes that
vary in the population. While only the extreme trait values
may be of clinical relevance, the full distribution in the
population provides additional power to identify genetic
determinants. However, the variation in trait value will
depend on the underlying genes, additional environmen-
tal factors, and other correlated phenotypes that may also
be under genetic control. The underlying trait distribution
after removing these factors may have higher power to
detect linkage. However, removing variation due to fac-
tors which themselves have a genetic basis (e.g., body
mass index in systolic blood pressure) may remove
genetic variation due to common genes contributing to
both phenotypes, or where the genes for the explanatory
variable (weight) contribute a major proportion of the
genetic variation in the major phenotype of interest
(systolic blood pressure).
In this study, we analyzed nine phenotypes from the
Genetic Analysis Workshop 13 Framingham Heart Study
data, based on systolic blood pressure (SBP). We explore
how the choice of underlying phenotype (maximum,
mean, or age-matched SBP) and correction for other vari-
ables affects the results of variance components linkage
analysis.
Methods
Three baseline SBP response variables were used in the
analysis: mean SBP, maximum SBP, and SBP at age 40 (to
analyze early onset cases). Mean and maximum SBP were
calculated for all study participants in Cohorts 1 and 2; no
age limit was imposed and no minimum number of SBP
readings were required for an individual to be included in
the analysis. For SBP at age 40, the value from the first visit
following a participant's fortieth birthday was used, or the
final reading if the participant was under age 40 at their
final study visit. Any participant who had no SBP recorded
between the ages of 35 and 45 years was excluded from
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the age 40 analysis. It was assumed that all missing data
occurred at random and would not bias results.
For each of the three response variables, three levels of
correction were applied. As well as the unadjusted
response (A), adjustments were made for epidemiological
and clinical covariates (B) and epidemiological covariates
only (C). Adjusted phenotypes were obtained from the
residuals after fitting a linear model using SPLUS v5.1.
COHORT was included in all adjusted phenotypes, other-
wise only those covariates that were statistically signifi-
cant at the 5% level using a forward model selection
process were included. For adjustment B, covariates
included in the variable selection process were age, sex,
cigarettes per day (SMOKE), units of alcohol per day
(DRINK), treatment for high blood pressure (TREATED),
and body mass index (BMI). Adjustment C included all
covariates except TREATED and BMI. For maximum SBP
and SBP at age 40, the corresponding covariate measure
was used. When analyzing mean SBP, the covariates
SMOKE, DRINK and TREATED were defined as yes or no
according to whether these factors has ever occurred. The
resulting nine phenotypes will be referred to as MAXSBP,
MEANSBP, and AGE40SBP with suffixes A, B and C refer-
ring to the three levels of correction (Table 1). All
response variables were log-transformed prior to adjust-
ment, since variance components analysis is sensitive to
non-normality of trait data [1]. Phenotypes were summa-
rized by calculating phenotypic and sib correlations
(Tables 1 and 2).
Extended pedigrees were split into nuclear families due to
the constraints of GENEHUNTER. In total, 294 nuclear
families (242 extended pedigrees) from 330 original ped-
igrees contributed to the analyses, having two or more
genotyped sibs with trait values for at least one of the phe-
notypes studied (Table 1). Quantitative trait multipoint
linkage analysis was performed using GENEHUNTER 2
[2,3]. The variance components (VC) method was used;
this method compares the maximum likelihood model of
Table 1: Phenotypic summary
Phenotype Final Model (models B and 
C include COHORT)
Sibling Correlation Mean No. Genotyped & 
Phenotyped Individuals per 
Family
Total No. Families
MAXSBP_A Unadjusted 0.554 3.17 294
MAXSBP_B TREATED, BMI, SEX 0.245 3.17 293
MAXSBP_C AGE, SEX 0.192 3.17 294
MEANSBP_A Unadjusted 0.460 3.17 294
MEANSBP_B TREATED, BMI, SEX, AGE, 
DRINK
0.304 3.17 294
MEANSBP_C SEX, AGE, DRINK SMOKE 0.278 3.17 294
AGE40SBP_A Unadjusted 0.317 3.17 294
AGE40SBP_B TREATED, BMI, SEX, 
DRINK
0.225 2.26 228
AGE40SBP_C SEX 0.189 3.00 269
Table 2: Phenotype correlations
Phenotype MAXSBP MEANSBP AGE40SBP
A B C A B C A B C
MAXSBP_A 1 0.73 0.78 0.89 0.57 0.67 0.68 0.47 0.46
MAXSBP_B 1 0.93 0.73 0.78 0.79 0.60 0.57 0.52
MAXSBP_C 1 0.77 0.75 0.88 0.65 0.53 0.61
MEANSBP_A 1 0.76 0.84 0.84 0.65 0.68
MEANSBP_B 1 0.90 0.66 0.71 0.63
MEANSBP_C 1 0.73 0.69 0.75
AGE40SBP_A 1 0.88 0.94
AGE40SBP_B 1 0.92
AGE40SBP_C 1
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the mean trait value from estimated environmental, poly-
genic, and quantitative tract loci (QTL) VC, with the null
model assuming no QTL. The likelihood ratio of these
models can be expressed as a LOD score, which is assessed
for significance using a standard chi-squared test. Male
and female trait values were estimated separately within
GENEHUNTER, and purely additive QTL effects were
assumed with no dominance variance.
Results
Genome-wide linkage analysis results for each of the nine
phenotypes are shown in Figure 1. The highest LOD score
was obtained for chromosome 8 by AGE40SBP_C (maxi-
mum LOD = 2.5 at GATA23D06). All of the phenotypes
except MAXSBP_A and AGE40SBP_B showed suggestive
evidence for linkage (Figure 2), defined by a LOD score >
1.9 [2,4]), although no correction for multiple testing
across phenotypes has been applied. The maximum LOD
score for AGE40SBP_B was 1.5; weaker evidence for link-
age using this phenotype may be due to the smaller sam-
ple size, as many individuals had no recorded DRINK
variable at that SBP measurement. Only MAXSBP_A failed
to reach a LOD score of 1.0. With the exception of the
unadjusted maximum SBP (MAXSBP_A), 30% to 40% of
the phenotypic variance is explained by a QTL in this
region. Most of the variance (>90%) in the MAXSBP_A
phenotype is explained by environmental factors.
Chromosomes 12 and 22 showed suggestive linkage with
MEANSBP_A only; the highest LOD score in these regions
from the remaining phenotypes was 1.1 (chromosome 12
AGE40SBP_A) and 1.4 (chromosome 22, AGE40SBP_A).
Genome-wide linkage results from VC analysisFigure 1
Genome-wide linkage results from VC analysis. Linked phenotype marked for regions with maximum LOD > 1.5.
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In total, 14 regions across the genome attained a LOD
score > 1.0. Of these, 11 included a phenotype adjusted
for epidemiological and clinical covariates (B), compared
with two unadjusted (A) and three adjusted for epidemi-
ological covariates only (C). These results are consistent
with the higher sib correlation observed for phenotypes B
than C (Table 1). Each SBP measure (maximum, mean,
age 40) contributed a similar number of high LOD scores.
Discussion
We have shown suggestive linkage to chromosome 8
between 0 and 40 cM, with similar evidence for localiza-
tion across most of the defined SBP phenotypes. No other
region of the genome showed such high LOD scores, or
such consistency across phenotypes. The chromosome 8
linkage results suggest that the gene(s) in this region con-
tribute directly to SBP, and not to an intermediate pheno-
type which has been corrected for (e.g., BMI). All SBP-
based phenotypes showed some evidence for linkage on
chromosome 8 (LOD > 1.5), except the unadjusted MAX-
SBP. Further analysis of SBP corrected for individual epi-
demiological and clinical factors might identify the crucial
factors to be included in the correction for SBP.
The maximum LOD score over the nine traits is 2.5.
Although multiple testing has been performed, we note
that the traits are not independent (Table 2) and that eight
give suggestive LOD scores greater than 1.5. A Bonferroni
correction would therefore be unnecessarily conservative.
A multivariate phenotype analysis may be preferable, but
is beyond the scope of this article.
Estimates of the environmental variance remain relatively
constant as QTL location varies. However, it is noticeable
that where high LOD scores are obtained, additive poly-
genic genetic variance is close to zero; that is, the putative
QTL explains almost all of the additive genetic variance.
This seems unlikely and leads us to consider possible devi-
ations from model assumptions. The most obvious is fail-
ure of normality, which has been shown to lead to
inflated type I error rates [1], but standard tests of normal-
ity showed no reason to doubt this assumption. One pos-
Chromosome 8p linked regionFigure 2
Chromosome 8p linked region. A, Multipoint LOD scores; B, Mean VC estimates.
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sible further check not implemented here would be the
simulation-based test described in Iturria et al. [5].
The Framingham Heart Study allows many choices of
summary measures from longitudinal data. We used max-
imum, mean, and age-specific SBP. The latter phenotype
gave the highest LOD score (2.5 on chromosome 8p) and
may reduce much of the age-dependent variation in SBP
which is present in other unadjusted phenotypes. For
example, the maximum SBP is treated similarly for study
participants from age 20–30, or from age 40–70, although
the distribution of SBP differs substantially in these age
ranges. The linkage results suggest that modelling by age
and epidemiological or clinical factors may increase the
power to detect linkage to SBP.
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